Long-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer. (Record no. 10287563)

MARC details
000 -LEADER
fixed length control field 01422 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513182905.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199905s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0028-4793
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1056/NEJM199905063401814
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Spitz, I M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19990512
245 00 - TITLE STATEMENT
Title Long-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The New England journal of medicine
Date of publication, distribution, etc. May 1999
300 ## - PHYSICAL DESCRIPTION
Extent 1439 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Androgen Antagonists
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyproterone Acetate
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Implants
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Flutamide
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gonadotropin-Releasing Hormone
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Luteinizing Hormone
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prostate-Specific Antigen
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prostatic Neoplasms
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Testosterone
General subdivision blood
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chertin, B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lindenberg, T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Farkas, A
773 0# - HOST ITEM ENTRY
Title The New England journal of medicine
Related parts vol. 340
-- no. 18
-- p. 1439
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1056/NEJM199905063401814">https://doi.org/10.1056/NEJM199905063401814</a>
Public note Available from publisher's website

No items available.